Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2020-08-25 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
对外担保管理制度
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and outlines the company's internal policies and procedures for providing external guarantees. It references relevant laws and regulations, internal control principles, approval processes, risk control, and responsibilities related to external guarantees. The document is a detailed internal governance policy rather than a financial report, earnings release, or announcement. It does not contain financial statements or data, nor is it a notice or announcement of a report. It is a governance-related document detailing company rules and procedures. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 4055 characters, which is substantive enough to be a full policy document rather than a brief announcement.
2020-08-25 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled 葵花药业集团股份有限公司董事会议事规则, which translates to 'Sunflower Pharmaceutical Group Co., Ltd. Board Meeting Rules'. The content details the internal rules and procedures governing the board of directors' meetings, including composition, responsibilities, meeting notices, proposals, voting, minutes, and execution of board decisions. It references relevant laws, company articles, and regulatory bodies like the China Securities Regulatory Commission and Shenzhen Stock Exchange. There is no financial data, earnings, audit opinions, or report disclosures. The document is a governance-related internal rules document, not a report or announcement of financial results or corporate actions. Therefore, it fits the category of Governance Information (CGR). The document length (11,101 characters) supports it being a full governance document rather than a brief announcement.
2020-08-25 Chinese
关于终止部分募集资金投资项目并永久补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the termination of part of its fundraising investment projects and the permanent replenishment of working capital. It details the background of the fundraising, the use of funds, the termination decision, and includes opinions from independent directors, the supervisory board, and the sponsoring institution. The document is a formal disclosure about changes in the use of raised capital and requires shareholder approval. It does not contain financial statements or detailed financial performance data, nor is it a transcript, report, or presentation. It is a regulatory announcement about capital use changes, fitting the category of Capital/Financing Update (CAP). The document length is about 4968 characters, which is substantive and not a mere brief notice or report publication announcement. Therefore, the best classification is CAP with high confidence.
2020-08-25 Chinese
第三届董事会第二十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 22nd meeting of the third board of directors of a company. It includes voting results on various proposals such as approval of the 2020 semi-annual report, special reports on fundraising usage, termination of some fundraising projects, and amendments to the company's articles and management systems. The document is a meeting resolution announcement by the board, not the actual semi-annual report or financial statements. It also includes references to independent directors' opinions and mentions that some proposals require shareholder meeting approval. The document length is 2681 characters, which is relatively short and consistent with a board meeting resolution announcement rather than a full financial report. Therefore, this document fits best under the category of Board/Management Information (MANG), as it announces board meeting decisions and management resolutions.
2020-08-25 Chinese
2020年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2020 年半年度报告摘要' which translates to '2020 Half-Year Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes management discussion on the impact of COVID-19 on business operations and strategic responses. The presence of comprehensive financial metrics and operational analysis indicates this is a substantive interim financial report rather than a brief announcement or summary. The document length is 4561 characters, which is sufficient to contain meaningful financial data and analysis. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-08-25 Chinese
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled as an "Investor Relations Management System" for a company, detailing policies, principles, organizational structure, and procedures for managing investor relations. It includes references to laws, regulations, and stock exchange rules, but does not contain financial statements, earnings data, or audit information. It is a governance-related document outlining internal rules and practices for investor communication and protection. It is not a report of financial results, audit, or meeting materials, nor an announcement of voting results or dividends. Therefore, the document best fits the category of Governance Information (CGR). The document length (7298 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2020-08-25 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.